Refine by
Biotherapeutics Product Equipment & Supplies In In Canada
8 equipment items found
Manufactured by:Adiso Therapeutics based inConcord, MASSACHUSETTS (USA)
ADS024 is an oral single strain live biotherapeutic product (SS-LBP). A naturally occurring live biotherapeutic product, ADS024 modulates inflammation as a single strain multimodal LBP and has been shown to reduce neutrophil trafficking through the colonic epithelium. ADS024 is manufactured from a pure, clonal bacterial ...
Manufactured by:Adiso Therapeutics based inConcord, MASSACHUSETTS (USA)
ADS024 is an oral single strain live biotherapeutic product (SS-LBP). A naturally occurring live biotherapeutic product, ADS024 possesses a dual mechanism of action. It is bactericidal toward Clostridioides difficile and degrades Toxins A and B produced by C. difficile while maintaining other components of the microbiome. ...
Manufactured by:Adiso Therapeutics based inConcord, MASSACHUSETTS (USA)
ADS00X has demonstrated pre-clinical efficacy in 3 models of neuroinflammatory disease. Adiso is pursuing confirmatory evidence which supports the impact of our SS-LBP products on the Gut-Brain Axis. ...
Manufactured by:Microviable Therapeutics SL based inGijón, SPAIN
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in human ...
Manufactured by:ICL, Inc. based inPortland, OREGON (USA)
Beta-2 microglobulin (B2M) is a host cell protein (HCP) generated by CHO cells during production of biotherapeutics. This process-related impurity accumulates in the extracellular space as it is released from dead CHO cells and secreted from viable cells during cell culture. Because it contains 22 immunoglobulin-like domains, B2M co-elutes with monoclonal ...
Manufactured by:ICL, Inc. based inPortland, OREGON (USA)
Annexin A5 is a host cell protein (HCP) generated by CHO cells during production of biotherapeutics. This process-related impurity accumulates in the extracellular space as it is released from dead CHO cells and secreted from viable cells during cell culture. Annexin A5 is highly immunogenic and may cause dangerous adverse reactions if present in a therapeutic ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
MAM has been broadly embraced by the biotherapeutic industry and regulatory leaders in recent years. Major biopharmaceutical companies are making significant investments to establish a MAM workflow to future proof the development and manufacturing of their biotherapeutics. Historically, the implementation of MAM has not been easy or fast due to the absence of a complete commercial MAM solution. ...
Manufactured by:Moon (Guangzhou) Biotech Co.,Ltd based inHuangpu District, CHINA
From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based drugs for improving human health and treating diseases. MoonBiotech is moving to a clinical-stage biotech company focused on the development of innovative microbiome-driven therapeutics. Our ...